Personalized Vaccination in Fusion+ Sarcoma Patients (PerVision)

NCT06094101 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Ewing Sarcoma
Rhabdomyosarcoma
Synovial Sarcoma

Interventions

BIOLOGICAL: Peptide vaccine IPX

Sponsor

University Hospital Tuebingen

Collaborators

[object Object]
[object Object]
[object Object]